Acrivon Therapeutics (NASDAQ:ACRV) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Acrivon Therapeutics missed estimated earnings by -18.0%, reporting an EPS of $-0.86 versus an estimate of $-0.73.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 5.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Acrivon Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
